Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for CRISPR Therapeutics (CRSP): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
29 analysts
Options Flow (P/C)
0.33
More calls — Bullish
Avg Consensus PT
$72
+39.4%
Highest Price Target
$120
+131.7%
Lowest Price Target
$32
-38.2%
Short Interest
22.2%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | Citizens | Silvan Turkcan— | +54.4% | $80 → $80 | Maintained | Market Outperform |
| Aug 31, 2026 | Needham | Gil Blum— | +58.3% | $82 → $82 | Maintained | Buy |